Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
MediWound Ltd. (MDWD)
USD14.18
-0.07 (-0.48%)
IL NASDAQ Healthcare Biotechnology
Address
42 Hayarkon Street 8122745
Yavne, IL
Yavne, IL
CEO
Ofer Gonen
Website
mediwound.com
IPO
2014-03-20
CIK 1593984 ISIN IL0011316309
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD14.18
-0.07 (-0.48%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
96.0K
Beta
0.15
Float Shares
8.83M
Free Float %
81.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -14.09% | -14.96% | -13.52% | -17.17% | -20.03% | -22.37% | -32.79% | +59.40% | -41.51% | -73.62% | -88.15% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (13 ratings, all time)
Buy
Price Targets & DCF
Current price
14.18
Low
32.00
+125.7%
Consensus
32.00
+125.7%
Median
32.00
+125.7%
High
32.00
+125.7%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 5 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
32.00
+125.7%
|
| Last Quarter | 1 |
32.00
+125.7%
|
| Last Year | 2 |
34.00
+139.8%
|
| All Time | 10 |
27.58
+94.5%
|
Quality scores
Altman Z-Score
1.98
Grey zone
Piotroski F-Score
3 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-16.1% Q1'26: -62.7% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+30.7% ★ Q1'26: -242.3% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-114.4% Q1'26: -581.3% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-137.6% Q1'26: -541.0% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: -647.3% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+14.2% Q1'26: +19.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.41× Q1'26: -0.27× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 5 EPS Ana. |
Dec 2027 6 Rev. Ana. 5 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
259.0K
est: 247.4K (+4.7%)
|
601.0K
est: 546.8K (+9.9%)
|
1.56M
est: 1.85M (-15.6%)
|
2.50M
est: 2.57M (-2.9%)
|
3.40M
est: 3.14M (+8.2%)
|
31.79M
est: 30.43M (+4.5%)
|
21.76M
est: 20.68M (+5.3%)
|
23.76M
est: 23.85M (-0.4%)
|
26.50M
est: 21.53M (+23.0%)
|
18.69M
est: 20.14M (-7.2%)
|
20.22M
est: 20.15M (+0.4%)
|
16.96M
est: 18.12M (-6.4%)
|
24.76M
24.08M – 25.32M
+36.6% YoY
|
33.44M
32.49M – 34.46M
+35.0% YoY
|
53.59M
52.08M – 55.04M
+60.3% YoY
|
109.36M
106.28M – 112.32M
+104.1% YoY
|
181.41M
176.32M – 186.33M
+65.9% YoY
|
| EBITDA |
-17.59M
est: -13.99M (-25.7%)
|
-20.32M
est: -16.66M (-22.0%)
|
-17.45M
est: -16.81M (-3.8%)
|
-13.14M
est: -1.45M (-806.2%)
|
-4.20M
est: -1.77M (-136.6%)
|
4.14M
est: -17.17M (+124.1%)
|
-7.35M
est: -11.88M (+38.1%)
|
-11.38M
est: -13.46M (+15.4%)
|
-18.25M
est: -10.34M (-76.5%)
|
-4.80M
est: -13.80M (+65.2%)
|
-27.93M
est: -13.80M (-102.4%)
|
-21.47M
est: -12.41M (-73.0%)
|
-16.96M
-17.34M – -16.49M
-36.6% YoY
|
-22.90M
-23.60M – -22.25M
-35.0% YoY
|
-36.70M
-37.70M – -35.67M
-60.3% YoY
|
-74.90M
-76.93M – -72.80M
-104.1% YoY
|
-124.26M
-127.62M – -120.77M
-65.9% YoY
|
| EBIT |
-18.08M
est: -21.30M (+15.1%)
|
-20.83M
est: -19.61M (-6.2%)
|
-18.04M
est: -20.61M (+12.5%)
|
-13.71M
est: -1.56M (-777.0%)
|
-4.77M
est: -1.91M (-149.7%)
|
2.99M
est: -18.51M (+116.2%)
|
-8.44M
est: -11.05M (+23.6%)
|
-12.62M
est: -14.51M (+13.0%)
|
-19.52M
est: -12.22M (-59.8%)
|
-6.10M
est: -14.48M (+57.8%)
|
-29.41M
est: -14.48M (-103.1%)
|
-23.33M
est: -13.03M (-79.1%)
|
-17.80M
-18.20M – -17.31M
-36.6% YoY
|
-24.04M
-24.77M – -23.35M
-35.0% YoY
|
-38.52M
-39.57M – -37.44M
-60.3% YoY
|
-78.62M
-80.75M – -76.41M
-104.1% YoY
|
-130.42M
-133.95M – -126.75M
-65.9% YoY
|
| Net Income |
-18.88M
est: -16.50M (-14.4%)
|
-22.09M
est: -19.01M (-16.2%)
|
-18.89M
est: -17.68M (-6.8%)
|
-22.15M
est: -68.88M (+67.8%)
|
-1.06M
est: -40.57M (+97.4%)
|
4.96M
est: 130.25M (-96.2%)
|
-9.20M
est: -11.44M (+19.6%)
|
-13.55M
est: -34.19M (+60.4%)
|
-19.60M
est: -14.43M (-35.8%)
|
-6.72M
est: -24.58M (+72.7%)
|
-30.22M
est: -37.59M (+19.6%)
|
-23.88M
est: -23.88M (+0.0%)
|
-35.25M
-37.68M – -24.02M
-47.6% YoY
|
-27.79M
-29.83M – -15.94M
+21.2% YoY
|
-12.68M
-17.18M – -8.19M
+54.4% YoY
|
8.08M
7.78M – 8.36M
+163.7% YoY
|
31.10M
29.96M – 32.19M
+285.0% YoY
|
| SGA |
13.50M
est: 120.1K (+11,142.7%)
|
13.23M
est: 265.4K (+4,884.9%)
|
12.42M
est: 896.4K (+1,285.7%)
|
9.09M
est: 1.25M (+628.7%)
|
7.94M
est: 1.53M (+420.8%)
|
9.06M
est: 14.77M (-38.7%)
|
8.50M
est: 14.99M (-43.3%)
|
9.45M
est: 11.58M (-18.3%)
|
10.37M
est: 10.66M (-2.7%)
|
11.38M
est: 11.51M (-1.2%)
|
12.91M
est: 11.51M (+12.1%)
|
13.93M
est: 10.36M (+34.5%)
|
14.15M
13.76M – 14.47M
+36.6% YoY
|
19.11M
18.57M – 19.69M
+35.0% YoY
|
30.63M
29.77M – 31.46M
+60.3% YoY
|
62.50M
60.74M – 64.19M
+104.1% YoY
|
103.68M
100.77M – 106.49M
+65.9% YoY
|
| EPS |
-6.65
est: -0.84 (-696.4%)
|
-7.13
est: -6.14 (-16.1%)
|
-6.05
est: -7.03 (+13.9%)
|
-6.64
est: -6.92 (+4.0%)
|
-0.28
est: -4.07 (+93.1%)
|
1.26
est: 1.43 (-12.2%)
|
-2.38
est: -2.73 (+12.8%)
|
-3.48
est: -3.43 (-1.4%)
|
-3.93
est: -2.02 (-94.3%)
|
-0.75
est: -2.16 (+65.3%)
|
-3.03
est: -3.28 (+7.7%)
|
-2.10
est: -2.16 (+2.8%)
|
-2.75
-3.31 – -2.11
-27.3% YoY
|
-2.04
-2.62 – -1.40
+25.8% YoY
|
-1.24
-1.51 – -0.72
+39.1% YoY
|
0.71
0.68 – 0.74
+157.1% YoY
|
2.73
2.63 – 2.83
+285.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-26 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-14 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-26.66M
OE per share TTM
-2.21
Owner's Yield
-14.51%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
49.6%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
77
Total invested
97.01M
Insider transactions (90d)
0
Beneficial owners (>5%)
39
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Access Industries, LLC | 10.99M | 26.92% | — | 10.99M | — | 11.00 | OO | — | 2022-09-26 | ↗ |
| 2 | Clal Industries Ltd. | 10.99M | 26.92% | — | 10.99M | — | 11.00 | CO | — | 2022-09-26 | ↗ |
| 3 | LLC | 10.99M | 26.92% | — | 10.99M | — | 11.00 | OO | — | 2022-09-26 | ↗ |
| 4 | Len Blavatnik | 10.99M | 26.92% | — | 10.99M | — | 11.00 | IN | — | 2022-09-26 | ↗ |
| 5 | Ltd. | 10.99M | 26.92% | 2.78M | 8.21M | 2.78M | 11.00 | CO | — | 2022-09-26 | ↗ |
| 6 | Access Industries Holdings LLC | 10.95M | 33.68% | — | 10.95M | — | 10.95M | OO | — | 2022-03-17 | ↗ |
| 7 | Access Industries Management, LLC | 10.95M | 33.68% | — | 10.95M | — | 10.95M | OO | — | 2022-03-17 | ↗ |
| 8 | Clal Biotechnology Industries Ltd. | 10.95M | 33.68% | 2.75M | 8.21M | 2.75M | 8.21M | CO | — | 2022-03-17 | ↗ |
| 9 | Clal Life Sciences L.P. | 8.21M | 20.16% | — | 8.21M | — | 11.00 | PN | — | 2022-09-26 | ↗ |
| 10 | Barak Ben-Eliezer | 5.72M | 12.30% | — | 5.72M | — | 5.72M | IN | Place of Organization | 2022-12-05 | ↗ |
| 11 | Deep Insight Fund GP Limited Partnership | 5.72M | 12.30% | — | 5.72M | — | 5.72M | PN | Place of Organization | 2022-12-05 | ↗ |
| 12 | Deep Insight GP Ltd. | 5.72M | 12.30% | — | 5.72M | — | 5.72M | CO | Place of Organization | 2022-12-05 | ↗ |
| 13 | Deep Insight Limited Partnership | 5.72M | 12.30% | — | 5.72M | — | 5.72M | PN | Place of Organization | 2022-12-05 | ↗ |
| 14 | Deep Insight Management Ltd. | 5.72M | 12.30% | — | 5.72M | — | 5.72M | CO | Place of Organization | 2022-12-05 | ↗ |
| 15 | Dr. Eyal Kishon | 5.72M | 12.30% | — | 5.72M | — | 5.72M | IN | Place of Organization | 2022-12-05 | ↗ |
| 16 | Israel Biotech Fund II, L.P. | 5.72M | 12.30% | — | 5.72M | — | 5.72M | PN | Cayman Islands | 2022-12-05 | ↗ |
| 17 | Lior Rosenberg | 1.96M | 7.18% | 254.7K | 1.71M | 254.7K | — | IN | Israel | 2021-02-02 | ↗ |
| 18 | L.R. Research & Development Ltd. | 1.71M | 6.25% | — | 1.71M | — | — | CO | Israel | 2021-02-02 | ↗ |
| 19 | Wellington Management Group LLP | 1.08M | 3.99% | — | 993.5K | — | 1.08M | HC | Delaware | 2020-06-09 | ↗ |
| 20 | Investor AB | 872.1K | 8.10% | 872.1K | — | 872.1K | 10.00 | OO | — | 2024-07-19 | ↗ |
| 21 | MHC Sweden AB | 872.1K | 8.10% | 872.1K | — | 872.1K | 10.00 | OO | — | 2024-07-19 | ↗ |
| 22 | Mölnlycke AB | 872.1K | 8.10% | 872.1K | — | 872.1K | 10.00 | OO | — | 2024-07-19 | ↗ |
| 23 | Mölnlycke Health Care AB | 872.1K | 8.10% | 872.1K | — | 872.1K | 10.00 | OO | — | 2024-07-19 | ↗ |
| 24 | Mölnlycke Holding AB | 872.1K | 8.10% | 872.1K | — | 872.1K | 10.00 | OO | — | 2024-07-19 | ↗ |
| 25 | Patricia Industries AB | 872.1K | 8.10% | 872.1K | — | 872.1K | 10.00 | OO | — | 2024-07-19 | ↗ |
| 26 | Rotca AB | 872.1K | 8.10% | 872.1K | — | 872.1K | 10.00 | OO | — | 2024-07-19 | ↗ |
| 27 | Point72 Asset Management, L.P. | 821.5K | 8.90% | — | 821.5K | — | 821.5K | PN | Citizenship or place of organization Delaware | 2023-02-08 | ↗ |
| 28 | Point72 Capital Advisors, Inc. | 821.5K | 8.90% | — | 821.5K | — | 821.5K | CO | Citizenship or place of organization Delaware | 2023-02-08 | ↗ |
| 29 | Steven A. Cohen | 821.5K | 8.90% | — | 821.5K | — | 821.5K | IN | Citizenship or place of organization United States | 2023-02-08 | ↗ |
| 30 | Lapidot | 750.7K | 6.96% | — | 750.7K | — | 750.7K | IN | Israel | 2024-10-01 | ↗ |
| 31 | Yelin | 750.7K | 6.96% | — | 750.7K | — | 750.7K | IN | Israel | 2024-10-01 | ↗ |
| 32 | Yelin Lapidot Holdings Management Ltd. | 750.7K | 6.96% | — | 750.7K | — | 750.7K | CO | Israel | 2024-10-01 | ↗ |
| 33 | Migdal Insurance & Financial Holdings Ltd | 216.9K | 0.00% | — | 216.9K | — | — | HC | Israel | 2022-02-02 | ↗ |
| 34 | Gilad Aharon | 163.3K | 6.10% | — | 163.3K | — | 163.3K | IN | ONTARIO, CANADA | 2022-12-21 | ↗ |
| 35 | Rosalind Master Fund L.P. | 163.3K | 6.10% | — | 163.3K | — | 163.3K | PN | CAYMAN ISLANDS | 2022-12-21 | ↗ |
| 36 | Steven Salamon | 163.3K | 6.10% | — | 163.3K | — | — | IN | ONTARIO, CANADA | 2022-12-21 | ↗ |
| 37 | Dov Yelin | 432.00 | 5.30% | — | 432.00 | — | — | IN | Israel | 2018-01-31 | ↗ |
| 38 | Yair Lapidot | 432.00 | 5.30% | — | 432.00 | — | — | IN | Israel | 2018-01-31 | ↗ |
| 39 | Yelin Lapidot Mutual Funds Management Ltd. | 432.00 | 5.30% | — | 432.00 | — | — | CO | Israel | 2018-01-31 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
77
-3 vs prev Q
New positions
17
Closed positions
19
Increased
44
Reduced
18
Put/Call ratio
0.00
Calls held
—
Puts held
53.6K
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | INVESTOR AB | 872.1K +— (+0.0%) | 16.10M +383.7K (+2.4%) | 7.91% -0.137 pp | 0.28% -0.020 pp | USD18.06 +2.2% | 6 qtrs — |
| 2 | YELIN LAPIDOT HOLDINGS MANAGEMENT LTD. | 763.1K -46.9K (-5.8%) | 14.09M -509.0K (-3.5%) | 6.92% -0.552 pp | 2.82% -0.242 pp | USD16.17 +14.2% | 10 qtrs — |
| 3 | ROSALIND ADVISORS, INC. | 749.1K +— (+0.0%) | 13.83M +329.6K (+2.4%) | 6.80% -0.117 pp | 4.86% +0.246 pp | USD14.66 +25.9% | 9 qtrs — |
| 4 | PRICE T ROWE ASSOCIATES INC /MD/ | 554.5K -60.0K (-9.8%) | 10.24M -837.0K (-7.6%) | 5.03% -0.641 pp | 0.00% 0.000 pp | USD17.84 +3.5% | 4 qtrs — |
| 5 | BLACKROCK, INC. | 455.8K +51.7K (+12.8%) | 8.41M +1.1M (+15.6%) | 4.13% +0.406 pp | 0.00% +0.000 pp | USD17.92 +3.0% | 6 qtrs — |
| 6 | MEITAV INVESTMENT HOUSE LTD | 371.6K +80.0K (+27.4%) | 6.86M +1.6M (+30.8%) | 3.37% +0.680 pp | 0.08% +0.010 pp | USD17.73 +4.1% | 13 qtrs — |
| 7 | KOTLER KEVIN | 337.2K +337.2K (+100.0%) | 6.23M +6.2M (+100.0%) | 3.06% +3.060 pp | 1.46% +1.456 pp | USD18.46 +0.0% | 1 qtrs NEW |
| 8 | SPHERA FUNDS MANAGEMENT LTD. | 230.3K +45.1K (+24.3%) | 4.25M +913.6K (+27.4%) | 2.09% +0.380 pp | 0.82% +0.118 pp | USD18.11 +1.9% | 2 qtrs — |
| 9 | SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC | 183.9K +11.1K (+6.4%) | 3.40M +281.1K (+9.0%) | 1.67% +0.074 pp | 1.96% +0.071 pp | USD14.71 +25.5% | 9 qtrs — |
| 10 | UBS GROUP AG | 145.1K +68.8K (+90.1%) | 2.68M +1.3M (+94.8%) | 1.32% +0.612 pp | 0.00% +0.000 pp | USD18.03 +2.4% | 8 qtrs — |
| 11 | STATE STREET CORP | 124.5K +12.1K (+10.7%) | 2.30M +272.2K (+13.4%) | 1.13% +0.092 pp | 0.00% +0.000 pp | USD17.97 +2.7% | 7 qtrs — |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 120.1K +22.3K (+22.8%) | 2.22M +454.1K (+25.8%) | 1.09% +0.187 pp | 0.00% +0.000 pp | USD16.03 +15.2% | 7 qtrs — |
| 13 | NORTHERN TRUST CORP | 119.7K +4.0K (+3.5%) | 2.21M +125.6K (+6.0%) | 1.09% +0.019 pp | 0.00% +0.000 pp | USD17.92 +3.0% | 6 qtrs — |
| 14 | DAFNA CAPITAL MANAGEMENT LLC | 113.6K +— (+0.0%) | 2.10M +50.0K (+2.4%) | 1.03% -0.018 pp | 0.49% -0.019 pp | USD15.43 +19.6% | 13 qtrs — |
| 15 | ARK INVESTMENT MANAGEMENT LLC | 106.4K +9.5K (+9.8%) | 1.96M +218.3K (+12.5%) | 0.97% +0.071 pp | 0.01% +0.003 pp | USD17.95 +2.8% | 6 qtrs — |
| 16 | MILLENNIUM MANAGEMENT LLC | 102.1K -73.3K (-41.8%) | 1.89M -1.3M (-40.3%) | 0.93% -0.692 pp | 0.00% -0.001 pp | USD18.32 +0.8% | 3 qtrs — |
| 17 | CITADEL ADVISORS LLC | 89.6K +89.6K (+100.0%) | 1.65M +1.7M (+100.0%) | 0.81% +0.813 pp | 0.00% +0.000 pp | USD18.46 +0.0% | 9 qtrs — |
| 18 | MORGAN STANLEY | 74.0K +23.0K (+45.2%) | 1.37M +447.5K (+48.8%) | 0.67% +0.201 pp | 0.00% +0.000 pp | USD17.56 +5.1% | 13 qtrs — |
| 19 | CLAL INSURANCE ENTERPRISES HOLDINGS LTD | 71.0K +13.2K (+22.8%) | 1.31M +269.0K (+25.8%) | 0.64% +0.111 pp | 0.01% +0.001 pp | USD18.10 +2.0% | 2 qtrs — |
| 20 | VANGUARD GROUP INC | 65.3K +14.2K (+27.8%) | 1.21M +284.6K (+30.9%) | 0.59% +0.121 pp | 0.00% +0.000 pp | USD16.30 +13.3% | 7 qtrs — |
| 21 | MENORA MIVTACHIM HOLDINGS LTD. | 65.1K -13.4K (-17.1%) | 1.20M -212.7K (-15.0%) | 0.59% -0.134 pp | 0.01% -0.002 pp | USD18.32 +0.8% | 3 qtrs — |
| 22 | SARGENT INVESTMENT GROUP, LLC | 59.9K +— (+0.0%) | 1.11M +26.4K (+2.4%) | 0.54% -0.009 pp | 0.14% -0.015 pp | USD13.92 +32.6% | 13 qtrs — |
| 23 | SUMMIT FINANCIAL, LLC | 48.0K +32.0K (+200.1%) | 886.0K +597.9K (+207.5%) | 0.44% +0.288 pp | 0.01% +0.009 pp | USD18.31 +0.8% | 2 qtrs — |
| 24 | BALYASNY ASSET MANAGEMENT L.P. | 38.1K -38.1K (-50.0%) | 704.2K -670.6K (-48.8%) | 0.35% -0.358 pp | 0.00% -0.001 pp | USD15.17 +21.7% | 8 qtrs — |
| 25 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 24.4K -29.6K (-54.8%) | 450.4K -522.7K (-53.7%) | 0.22% -0.277 pp | 0.00% 0.000 pp | USD18.27 +1.0% | 7 qtrs — |
| 26 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 24.3K +4.9K (+25.4%) | 448.1K +99.2K (+28.5%) | 0.22% +0.042 pp | 0.00% +0.000 pp | USD16.03 +15.2% | 7 qtrs — |
| 27 | MGO ONE SEVEN LLC | 22.2K -47.0 (-0.2%) | 409.1K +8.9K (+2.2%) | 0.20% -0.004 pp | 0.01% -0.001 pp | USD17.90 +3.1% | 9 qtrs — |
| 28 | LPL FINANCIAL LLC | 21.9K +4.7K (+27.4%) | 403.8K +94.5K (+30.5%) | 0.20% +0.040 pp | 0.00% +0.000 pp | USD18.88 -2.2% | 3 qtrs — |
| 29 | PVG ASSET MANAGEMENT CORP | 20.5K +390.0 (+1.9%) | 378.1K +16.0K (+4.4%) | 0.19% +0.000 pp | 0.80% -0.529 pp | USD18.03 +2.4% | 2 qtrs — |
| 30 | WELLS FARGO & COMPANY/MN | 20.2K +5.3K (+35.7%) | 372.6K +104.5K (+39.0%) | 0.18% +0.046 pp | 0.00% +0.000 pp | USD14.41 +28.1% | 13 qtrs — |
| 31 | OPPENHEIMER & CO INC | 20.1K +20.1K (+100.0%) | 370.9K +370.9K (+100.0%) | 0.18% +0.182 pp | 0.01% +0.005 pp | USD18.46 +0.0% | 1 qtrs NEW |
| 32 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 19.5K -10.6K (-35.3%) | 357.2K -186.3K (-34.3%) | 0.18% -0.101 pp | 0.00% 0.000 pp | USD17.56 +5.1% | 4 qtrs — |
| 33 | PHARVISION ADVISERS, LLC | 19.1K +19.1K (+100.0%) | 351.9K +351.9K (+100.0%) | 0.17% +0.173 pp | 0.18% +0.178 pp | USD18.46 +0.0% | 1 qtrs NEW |
| 34 | BANK OF NEW YORK MELLON CORP | 18.1K +1.5K (+9.1%) | 334.1K +35.2K (+11.8%) | 0.16% +0.011 pp | 0.00% +0.000 pp | USD15.66 +17.9% | 7 qtrs — |
| 35 | SQUAREPOINT OPS LLC | 16.1K +16.1K (+100.0%) | 297.2K +297.2K (+100.0%) | 0.15% +0.146 pp | 0.00% +0.000 pp | USD18.46 +0.0% | 1 qtrs NEW |
| 36 | BARCLAYS PLC | 15.3K +4.1K (+36.8%) | 282.0K +80.4K (+39.9%) | 0.14% +0.036 pp | 0.00% +0.000 pp | USD18.11 +1.9% | 7 qtrs — |
| 37 | ENVESTNET ASSET MANAGEMENT INC | 15.1K +1.6K (+11.8%) | 278.8K +35.5K (+14.6%) | 0.14% +0.012 pp | 0.00% +0.000 pp | USD18.07 +2.2% | 2 qtrs — |
| 38 | J. GOLDMAN & CO LP | 13.1K +— (+0.0%) | 241.3K +5.8K (+2.4%) | 0.12% -0.002 pp | 0.01% +0.000 pp | USD18.06 +2.2% | 6 qtrs — |
| 39 | — | 11.3K +11.3K (+100.0%) | 208.2K +208.2K (+100.0%) | 0.10% +0.102 pp | 0.04% +0.044 pp | USD18.46 +0.0% | 1 qtrs NEW |
| 40 | JANE STREET GROUP, LLC | 10.9K -33.4K (-75.4%) | 201.5K -597.6K (-74.8%) | 0.10% -0.310 pp | 0.00% 0.000 pp | USD18.48 -0.1% | 3 qtrs — |
| 41 | RHUMBLINE ADVISERS | 10.9K +65.0 (+0.6%) | 200.6K +6.0K (+3.1%) | 0.10% -0.001 pp | 0.00% +0.000 pp | USD16.23 +13.7% | 7 qtrs — |
| 42 | NUVEEN, LLC | 10.8K +— (+0.0%) | 199.4K +4.8K (+2.4%) | 0.10% -0.002 pp | 0.00% +0.000 pp | USD15.52 +18.9% | 4 qtrs — |
| 43 | BANK OF AMERICA CORP /DE/ | 8.4K -3.5K (-29.5%) | 154.4K -59.4K (-27.8%) | 0.08% -0.034 pp | 0.00% +0.000 pp | USD17.19 +7.4% | 8 qtrs — |
| 44 | DEUTSCHE BANK AG\ | 8.0K +3.5K (+79.6%) | 147.1K +67.2K (+84.0%) | 0.07% +0.031 pp | 0.00% +0.000 pp | USD16.88 +9.4% | 7 qtrs — |
| 45 | METLIFE INVESTMENT MANAGEMENT, LLC | 5.9K +5.9K (+100.0%) | 109.1K +109.1K (+100.0%) | 0.05% +0.054 pp | 0.00% +0.001 pp | USD18.46 +0.0% | 6 qtrs — |
| 46 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 4.5K +956.0 (+26.6%) | 83.9K +19.2K (+29.7%) | 0.04% +0.008 pp | 0.00% +0.000 pp | USD17.78 +3.8% | 6 qtrs — |
| 47 | JPMORGAN CHASE & CO | 4.0K +830.0 (+26.1%) | 74.1K +16.7K (+29.2%) | 0.04% +0.007 pp | 0.00% +0.000 pp | USD15.44 +19.6% | 9 qtrs — |
| 48 | RUSSELL INVESTMENTS GROUP, LTD. | 3.7K +1.1K (+45.1%) | 67.4K +22.1K (+48.6%) | 0.03% +0.010 pp | 0.00% +0.000 pp | USD18.37 +0.5% | 6 qtrs — |
| 49 | NEW YORK STATE COMMON RETIREMENT FUND | 3.5K +— (+0.0%) | 64.6K +1.5K (+2.4%) | 0.03% -0.001 pp | 0.00% +0.000 pp | USD15.39 +19.9% | 7 qtrs — |
| 50 | FMR LLC | 3.0K -462.0 (-13.2%) | 56.1K -7.0K (-11.1%) | 0.03% -0.005 pp | 0.00% +0.000 pp | USD17.55 +5.2% | 6 qtrs — |
| 51 | PINNACLE WEALTH PLANNING SERVICES, INC. | 2.5K +2.5K (+100.0%) | 45.7K +45.7K (+100.0%) | 0.02% +0.023 pp | 0.00% +0.005 pp | USD18.46 +0.0% | 1 qtrs NEW |
| 52 | BNP PARIBAS ARBITRAGE, SNC | 2.1K +530.0 (+34.8%) | 37.9K +10.5K (+38.1%) | 0.02% +0.005 pp | 0.00% +0.000 pp | USD18.21 +1.4% | 5 qtrs — |
| 53 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 1.6K +— (+0.0%) | 29.7K +709.0 (+2.4%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD17.80 +3.7% | 5 qtrs — |
| 54 | QUARRY LP | 1.4K +1.4K (+100.0%) | 25.9K +25.9K (+100.0%) | 0.01% +0.013 pp | 0.00% +0.004 pp | USD18.46 +0.0% | 1 qtrs NEW |
| 55 | LEGAL & GENERAL GROUP PLC | 1.1K +214.0 (+25.1%) | 19.7K +4.3K (+28.2%) | 0.01% +0.002 pp | 0.00% +0.000 pp | USD16.02 +15.2% | 7 qtrs — |
| 56 | RONALD BLUE TRUST, INC. | 940.00 +— (+0.0%) | 17.4K +413.0 (+2.4%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD18.06 +2.2% | 6 qtrs — |
| 57 | AMERITAS INVESTMENT PARTNERS, INC. | 785.00 +— (+0.0%) | 14.5K +345.0 (+2.4%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD15.39 +19.9% | 7 qtrs — |
| 58 | TOWER RESEARCH CAPITAL LLC (TRC) | 609.00 -291.0 (-32.3%) | 11.2K -5.0K (-30.7%) | 0.01% -0.003 pp | 0.00% 0.000 pp | USD18.89 -2.3% | 13 qtrs — |
| 59 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 599.00 +18.0 (+3.1%) | 11.1K +588.0 (+5.6%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD15.49 +19.2% | 7 qtrs — |
| 60 | ADVISOR GROUP HOLDINGS, INC. | 366.00 -5.0K (-93.2%) | 6.8K -83.8K (-92.5%) | 0.00% -0.047 pp | 0.00% 0.000 pp | USD14.49 +27.4% | 13 qtrs — |
| 61 | AMALGAMATED BANK | 306.00 +29.0 (+10.5%) | 6.0K +1.0K (+20.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD15.68 +17.7% | 7 qtrs — |
| 62 | ROYAL BANK OF CANADA | 316.00 -228.0 (-41.9%) | 5.0K -5.0K (-50.0%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD18.02 +2.4% | 9 qtrs — |
| 63 | CITIGROUP INC | 227.00 -82.0 (-26.5%) | 4.2K -1.4K (-24.7%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD16.78 +10.0% | 7 qtrs — |
| 64 | GENEOS WEALTH MANAGEMENT INC. | 215.00 +— (+0.0%) | 4.0K +95.0 (+2.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD17.80 +3.7% | 5 qtrs — |
| 65 | PNC FINANCIAL SERVICES GROUP, INC. | 129.00 +129.0 (+100.0%) | 2.4K +2.4K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD18.46 +0.0% | 1 qtrs NEW |
| 66 | GROUP ONE TRADING, L.P. | 100.00 +100.0 (+100.0%) | 1.8K +1.8K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD18.46 +0.0% | 1 qtrs NEW |
| 67 | STERLING CAPITAL MANAGEMENT LLC | 85.00 +30.0 (+54.5%) | 1.6K +578.0 (+58.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD18.61 -0.8% | 6 qtrs — |
| 68 | OPTIVER HOLDING B.V. | 66.00 +6.0 (+10.0%) | 1.2K +154.0 (+14.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD18.05 +2.3% | 2 qtrs — |
| 69 | MASSMUTUAL TRUST CO FSB/ADV | 61.00 +61.0 (+100.0%) | 1.1K +1.1K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD18.46 +0.0% | 1 qtrs NEW |
| 70 | GAMMA INVESTING LLC | 57.00 -7.0 (-10.9%) | 1.1K -101.0 (-8.8%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD17.70 +4.3% | 6 qtrs — |
| 71 | ASSETMARK, INC | 57.00 +57.0 (+100.0%) | 1.1K +1.1K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD18.46 +0.0% | 1 qtrs NEW |
| 72 | CWM, LLC | 54.00 +2.0 (+3.8%) | 1.0K +— (+0.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD19.28 -4.3% | 3 qtrs — |
| 73 | STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 42.00 +— (+0.0%) | 775.00 +18.0 (+2.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD17.79 +3.8% | 5 qtrs — |
| 74 | NISA INVESTMENT ADVISORS, LLC | 16.00 +— (+0.0%) | 295.00 +7.0 (+2.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD15.50 +19.1% | 4 qtrs — |
| 75 | JONES FINANCIAL COMPANIES LLLP | 8.00 +8.0 (+100.0%) | 148.00 +148.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD18.38 +0.4% | 1 qtrs NEW |
| 76 | IFP ADVISORS, INC | 1.00 +— (+0.0%) | 18.00 +— (+0.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD18.00 +2.6% | 2 qtrs — |
| 77 | GOLDMAN SACHS GROUP INC | — -13.2K (-100.0%) | — -237.2K (-100.0%) | 0.00% -0.122 pp | 0.00% +0.000 pp | USD— | 6 qtrs SOLD |
| 78 | R SQUARED LTD | — -10.8K (-100.0%) | — -194.0K (-100.0%) | 0.00% -0.099 pp | 0.00% -0.084 pp | USD— | 2 qtrs SOLD |
| 79 | HUDSON BAY CAPITAL MANAGEMENT LP | — -10.0K (-100.0%) | — -180.2K (-100.0%) | 0.00% -0.092 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 80 | POINT72 ASSET MANAGEMENT, L.P. | — -61.0K (-100.0%) | — -1.1M (-100.0%) | 0.00% -0.563 pp | 0.00% -0.002 pp | USD— | 2 qtrs SOLD |
| 81 | TRUE WEALTH DESIGN, LLC | — -1.0 (-100.0%) | — -19.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
| 82 | ATOM INVESTORS LP | — -21.3K (-100.0%) | — -384.3K (-100.0%) | 0.00% -0.197 pp | 0.00% -0.029 pp | USD— | 2 qtrs SOLD |
| 83 | MARSHALL WACE, LLP | — -20.7K (-100.0%) | — -372.1K (-100.0%) | 0.00% -0.191 pp | 0.00% 0.000 pp | USD— | 3 qtrs SOLD |
| 84 | SRS CAPITAL ADVISORS, INC. | — -31.0 (-100.0%) | — -559.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 85 | ADVISORY SERVICES NETWORK, LLC | — -143.0 (-100.0%) | — -2.6K (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 86 | SIMPLEX TRADING, LLC | — -17.2K (-100.0%) | — -309.0K (-100.0%) | 0.00% -0.159 pp | 0.00% 0.000 pp | USD— | 8 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 28 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | ARK Israel Innovative Technology ETF IZRL | 1.32% | 1.86M | 0.49% |
| 2 | iShares Micro-Cap ETF IWC | 0.03% | 488.3K | 0.60% |
| 3 | iShares Russell 2000 Growth ETF IWO | 0.01% | 1.31M | 0.24% |
| 4 | Vanguard Russell 2000 Growth ETF VTWG | 0.01% | 120.6K | 0.06% |
| 5 | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) R2US.L | 0.00% | 278.7K | 0.30% |
| 6 | Xtrackers Russell 2000 UCITS ETF 1C XRSU.L | 0.00% | 139.6K | 0.30% |
| 7 | Global X - Russell 2000 ETF RSSL | 0.00% | 68.4K | 0.08% |
| 8 | Invesco Russell 2000 UCITS ETF RTYS.L | 0.00% | 14.8K | 0.25% |
| 9 | iShares Russell 2000 BuyWrite ETF IWMW | 0.00% | 2.4K | 0.39% |
| 10 | iShares Russell 2000 ETF IWM | 0.00% | 3.51M | 0.19% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
0
Sells
0
Shares acquired
—
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+0
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-18 | WILLS STEPHEN T | Director | — | — | Ordinary shares | 0 | 0.00 | — | 9,679 | D | ↗ |
| 2026-03-18 | SHAMIR NACHUM | Director | — | — | Stock Option (right to buy ordinary shares) | 10,000 | 17.60 | 176.0K | 0 | D | ↗ |
| 2026-03-18 | Rubinstein Samuel | Director | — | — | Ordinary shares | 0 | 0.00 | — | 525 | I | ↗ |
| 2026-03-18 | Meyer Yaron | Officer | — | — | Ordinary shares | 0 | 0.00 | — | 2,357 | D | ↗ |
| 2026-03-18 | Luxenburg Kalfon Hana | Officer | — | — | Ordinary shares | 0 | 0.00 | — | 4,085 | D | ↗ |
| 2026-03-18 | Klinger Ety | Officer | — | — | Stock Option (right to buy ordinary shares) | 15,000 | 17.60 | 264.0K | 0 | D | ↗ |
| 2026-03-18 | Hess Shmuel | Officer | — | — | Ordinary shares | 0 | 0.00 | — | 4,085 | D | ↗ |
| 2026-03-18 | Gonen Ofer | Officer | — | — | Ordinary shares | 0 | 0.00 | — | 35,714 | D | ↗ |
| 2026-03-18 | Fox David Morton | Director | — | — | Ordinary shares | 0 | 0.00 | — | 18,746 | D | ↗ |
| 2026-03-18 | Driver Vickie Rae | Director | — | — | Ordinary shares | 0 | 0.00 | — | 750 | D | ↗ |
| 2026-03-18 | Ben Yaakov Aya | Officer | — | — | Ordinary shares | 0 | 0.00 | — | 1,800 | D | ↗ |
| 2026-02-11 | WILLS STEPHEN T | Director | — | — | Stock Option (right to buy ordinary shares) | 5,600 | 18.54 | 103.8K | 0 | D | ↗ |
| 2026-02-11 | SHAMIR NACHUM | Director | — | — | Stock Option (right to buy ordinary shares) | 9,200 | 18.54 | 170.6K | 0 | D | ↗ |
| 2026-02-11 | Rubinstein Samuel | Director | — | — | Stock Option (right to buy ordinary shares) | 5,600 | 18.54 | 103.8K | 0 | D | ↗ |
| 2026-02-11 | Fox David Morton | Director | — | — | Stock Option (right to buy ordinary shares) | 5,600 | 18.54 | 103.8K | 0 | D | ↗ |
| 2026-02-11 | Driver Vickie Rae | Director | — | — | Stock Option (right to buy ordinary shares) | 5,600 | 18.54 | 103.8K | 0 | D | ↗ |
| 2025-03-04 | Meyer Yaron | Officer | — | — | Stock Option (right to buy ordinary shares) | 2,769 | 37.52 | 103.9K | 0 | D | ↗ |
| 2025-03-04 | Klinger Ety | Officer | — | — | Stock Option (right to buy ordinary shares) | 3,323 | 37.52 | 124.7K | 0 | D | ↗ |
| 2025-03-04 | Ben Yaakov Aya | Officer | — | — | Stock Option (right to buy ordinary shares) | 357 | 37.52 | 13.4K | 0 | D | ↗ |
| 2025-02-26 | WILLS STEPHEN T | Director | — | — | Stock Option (right to buy ordinary shares) | 7,542 | 12.73 | 96.0K | 0 | D | ↗ |
| 2025-02-26 | SHAMIR NACHUM | Director | — | — | Stock Option (right to buy ordinary shares) | 12,570 | 12.73 | 160.0K | 0 | D | ↗ |
| 2025-02-26 | Rubinstein Samuel | Director | — | — | Stock Option (right to buy ordinary shares) | 7,542 | 12.73 | 96.0K | 0 | D | ↗ |
| 2025-02-26 | Fox David Morton | Director | — | — | Stock Option (right to buy ordinary shares) | 7,542 | 12.73 | 96.0K | 0 | D | ↗ |
| 2025-02-26 | Driver Vickie Rae | Director | — | — | Stock Option (right to buy ordinary shares) | 7,542 | 12.73 | 96.0K | 0 | D | ↗ |
| 2024-08-15 | Rubinstein Samuel | Director | — | — | Stock Option (right to buy ordinary shares) | 7,200 | 9.64 | 69.4K | 0 | D | ↗ |
| 2024-05-31 | WILLS STEPHEN T | Director | — | — | Stock Option (right to buy ordinary shares) | 5,900 | 11.89 | 70.1K | 0 | D | ↗ |
| 2024-05-31 | SHAMIR NACHUM | Director | — | — | Stock Option (right to buy ordinary shares) | 11,800 | 11.89 | 140.2K | 0 | D | ↗ |
| 2024-05-31 | Fox David Morton | Director | — | — | Stock Option (right to buy ordinary shares) | 5,900 | 11.89 | 70.1K | 0 | D | ↗ |
| 2024-05-31 | Driver Vickie Rae | Director | — | — | Stock Option (right to buy ordinary shares) | 5,900 | 11.89 | 70.1K | 0 | D | ↗ |
| 2024-04-23 | Meyer Yaron | Officer | — | — | Stock Option (right to buy ordinary shares) | 4,919 | 12.25 | 60.3K | 0 | D | ↗ |
| 2024-04-23 | Klinger Ety | Officer | — | — | Stock Option (right to buy ordinary shares) | 5,491 | 12.25 | 67.3K | 0 | D | ↗ |
| 2024-04-23 | Ben Yaakov Aya | Officer | — | — | Stock Option (right to buy ordinary shares) | 571 | 12.25 | 7.0K | 0 | D | ↗ |
| 2023-08-17 | SHAMIR NACHUM | Director | — | — | Stock Option (right to buy ordinary shares) | 28,571 | 12.50 | 357.0K | 0 | D | ↗ |
| 2023-05-16 | WILLS STEPHEN T | Director | — | — | Stock Option (right to buy ordinary shares) | 10,714 | 14.42 | 154.5K | 0 | D | ↗ |
| 2023-05-16 | Fox David Morton | Director | — | — | Stock Option (right to buy ordinary shares) | 5,357 | 14.42 | 77.2K | 0 | D | ↗ |
| 2023-05-16 | Driver Vickie Rae | Director | — | — | Stock Option (right to buy ordinary shares) | 5,357 | 14.42 | 77.2K | 0 | D | ↗ |
| 2022-12-31 | Meyer Yaron | Officer | — | — | Stock Option (right to buy ordinary shares) | 2,857 | 36.05 | 103.0K | 0 | D | ↗ |
| 2022-12-31 | Klinger Ety | Officer | — | — | Stock Option (right to buy ordinary shares) | 3,571 | 36.05 | 128.7K | 0 | D | ↗ |
| 2022-12-31 | Ben Yaakov Aya | Officer | — | — | Stock Option (right to buy ordinary shares) | 1,571 | 36.05 | 56.6K | 0 | D | ↗ |
| 2022-11-28 | SHAMIR NACHUM | Director | — | — | Series A Warrants | 16,336 | 13.48 | 220.1K | 0 | D | ↗ |
| 2022-11-28 | Gonen Ofer | Officer | — | — | Series A Warrants | 8,168 | 13.48 | 110.1K | 0 | D | ↗ |
| 2022-11-28 | Fox David Morton | Director | — | — | Series A Warrants | 6,534 | 13.48 | 88.0K | 0 | D | ↗ |
| 2022-06-15 | WILLS STEPHEN T | Director | — | — | Stock Option (right to buy ordinary shares) | 3,214 | 37.52 | 120.6K | 0 | D | ↗ |
| 2022-06-15 | Fox David Morton | Director | — | — | Stock Option (right to buy ordinary shares) | 1,607 | 37.52 | 60.3K | 0 | D | ↗ |
| 2022-06-15 | Driver Vickie Rae | Director | — | — | Stock Option (right to buy ordinary shares) | 1,607 | 37.52 | 60.3K | 0 | D | ↗ |
| 2021-06-29 | WILLS STEPHEN T | Director | — | — | Stock Option (right to buy ordinary shares) | 14,285 | 12.25 | 175.0K | 0 | D | ↗ |
| 2021-06-29 | Fox David Morton | Director | — | — | Stock Option (right to buy ordinary shares) | 14,285 | 12.25 | 175.0K | 0 | D | ↗ |
| 2021-06-29 | Driver Vickie Rae | Director | — | — | Stock Option (right to buy ordinary shares) | 14,285 | 12.25 | 175.0K | 0 | D | ↗ |
| 2020-03-24 | WILLS STEPHEN T | Director | — | — | Stock Option (right to buy ordinary shares) | 2,857 | 34.43 | 98.4K | 0 | D | ↗ |
Executive team
Top executives
EBIT / Employee
-192.8K
Shares Outstanding
10.86M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ofer Gonen | Chief Executive Officer | 834.0K | male |
| Ety Klinger | Chief Medical Officer | 428.0K | — |
| Shmulik Hess | Chief Operating Officer & Chief Commercial Officer | 426.0K | — |
| Hani Luxenburg | Chief Financial Officer | 420.0K | female |
| Yaron Meyer Adv. | Executive Vice President, General Counsel & Corporate Secretary | 337.0K | male |
| Liron Gal | Vice President of Manufacturing Science & Technology | — | — |
| Hagit Mashiach | Vice President of Human Resources | — | female |
| Barry J. Wolfenson | Executive Vice President of Strategy & Corporate Development | — | male |
| Robert J. Snyder FFPM | Senior Vice President of Global Medical Affairs | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MDWD
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
